VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Exceptional Responses to Selpercatinib in RET Fusion-Driven Metastatic Pancreatic Cancer.
FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Exceptional Responses to Selpercatinib in RET Fusion-Driven Metastatic Pancreatic Cancer.
Exceptional Responses to Selpercatinib in RET Fusion-Driven Metastatic Pancreatic Cancer. JCO Precis Oncol. 2023 09; 7:e2300252.
View in:
PubMed
subject areas
Humans
Pancreatic Neoplasms
Proto-Oncogene Proteins c-ret
Pyrazoles
Pyridines
authors with profiles
SIREESHA YEDURURI
VIVEK SUBBIAH
JASON HUSE